Skip to main content
Clinical Trials/IRCT20200113046112N1
IRCT20200113046112N1
Recruiting
Phase 3

Assessing the efficacy of the prophylactic metformin administration in the prevention of gestational diabetes mellitus in non-diabetic obese pregnant women referred to Motahari Teaching Hospital

Oroumia University of Medical Sciences0 sites342 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Gestational Diabetes Mellitus in obese pregnant women.
Sponsor
Oroumia University of Medical Sciences
Enrollment
342
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age \>16 years
  • Gestational age \<3 months
  • Singleton pregnancy
  • Body mass index \=30

Exclusion Criteria

  • Multifetal pregnancy
  • Fetal anomaly
  • Previous history of diabetes mellitus, gestational diabetes mellitus, impaired fasting glucose or impaired glucose tolerance test
  • History of corticosteroid use
  • Heavy alcoholism
  • History of adverse or allergic reactions to metformin
  • History of underlying medical conditions (e.g. hypertension, renal failure, liver disease, malabsorption)

Outcomes

Primary Outcomes

Not specified

Similar Trials